Aetna Coverage

Does Aetna Cover GLP-1 Medications?

Aetna provides coverage for several GLP-1 medications, though coverage varies significantly by plan type. Most Aetna commercial plans cover Ozempic for type 2 diabetes. Wegovy coverage for weight management has expanded in 2025-2026, but many plans still require prior authorization and step therapy.

Reviewed by GlobalGLP1 Editorial Team • Updated April 2026 • Sources: publicly available formulary data

Medication Coverage

Medication Status Tier Notes
Ozempic (semaglutide) Covered Tier 3 (Preferred Brand) Covered for type 2 diabetes. Prior authorization required. Must try metformin first. Off-label use for weight loss is generally not covered.
Wegovy (semaglutide) Varies Tier 3-4 (Non-Preferred) FDA-approved for weight management. Coverage varies by plan. Many employer plans now include weight management. BMI 30+ or 27+ with comorbidity required.
Mounjaro (tirzepatide) Covered Tier 3 (Preferred Brand) Covered for type 2 diabetes. Prior authorization required. Off-label weight loss use typically not covered.
Zepbound (tirzepatide) Varies Tier 3-4 FDA-approved for weight management. Growing coverage across Aetna plans. Check your specific plan. BMI requirements apply.
Saxenda (liraglutide) Varies Tier 4 (Specialty) Limited coverage. Often requires failure of other weight loss methods.
Compounded semaglutide Not Covered N/A Not covered. Compounded medications are not FDA-approved and are excluded from most plans.

Prior Authorization

Most GLP-1 medications require prior authorization through Aetna. Your prescribing physician will need to submit documentation including diagnosis, BMI, and previous treatment history. Typical approval takes 5-10 business days.

Cost Estimates

With Insurance
$25-$150/month (after deductible)
Without Insurance
$800-$1,400/month

Savings tip: Aetna members can use the Aetna pharmacy discount program. Manufacturer savings cards (like Novo Nordisk's) can be combined with some plans to reduce copays further.

Requirements for Coverage

  • Valid prescription from a licensed healthcare provider
  • Prior authorization approval
  • BMI 30+ or BMI 27+ with weight-related comorbidity (for weight management medications)
  • Documentation of previous weight loss attempts (diet, exercise)
  • Step therapy: may need to try metformin or other first-line treatments

Tips for Getting Approved

1

Call the number on your Aetna card to verify your specific plan's formulary before starting treatment

2

Ask your doctor to submit prior authorization proactively to avoid delays

3

If denied, Aetna has a formal appeals process — success rates are higher with detailed clinical documentation

4

Check if your employer offers a separate obesity/weight management benefit

5

Aetna CVS Caremark plans may have different formulary placement than standard Aetna

Approval Statistics

Initial Approval
55-65%
Appeal Success
35-45%
Processing Time
5-10 business days

Approval rates vary by plan type and medication. Diabetes indications (Ozempic, Mounjaro) have higher initial approval rates than weight management indications (Wegovy, Zepbound).

Common Denial Reasons & How to Avoid Them

BMI not documented Common Denial

How to avoid: Ensure your doctor records your BMI at a recent office visit. A BMI measurement within 6 months is typically required.

Step therapy not completed Common Denial

How to avoid: Ask your doctor about a step therapy exception if you have a clinical reason to skip first-line treatments (e.g., metformin intolerance).

Off-label use (Ozempic for weight loss) Common Denial

How to avoid: Request Wegovy instead of Ozempic for weight management — it's FDA-approved for this indication and more likely to be covered.

Missing prior authorization Common Denial

How to avoid: Always get prior auth before filling the prescription. Retroactive authorizations are difficult to obtain.

Weight-related comorbidity not documented Common Denial

How to avoid: Have your doctor document all weight-related conditions (hypertension, sleep apnea, PCOS, joint pain, pre-diabetes) in your medical record.

Step Therapy Requirements

Wegovy / Zepbound (weight management)

Documented diet and exercise attempts (typically 3-6 months), may require trial of older weight loss medication or metformin depending on plan.

Ozempic / Mounjaro (diabetes)

First-line: metformin. Second-line: sulfonylurea or SGLT2 inhibitor. GLP-1 typically approved as third-line therapy.

Frequently Asked Questions

Aetna typically covers Ozempic only for type 2 diabetes, not specifically for weight loss. Ozempic is not FDA-approved for weight management, so off-label coverage is rare. For weight management, Wegovy (same active ingredient, higher dose) is FDA-approved and may be covered depending on your plan. Check your specific formulary.

Your prescribing doctor submits a prior authorization request to Aetna with your diagnosis, BMI, and treatment history. You can also call Aetna Precertification at the number on your member ID card to check status.

You have the right to appeal. Ask your doctor to submit a peer-to-peer review or a formal appeal with additional clinical documentation. Many initial denials are overturned on appeal.

Aetna Medicare Advantage plans cover Ozempic and Mounjaro for type 2 diabetes under Part D. The Inflation Reduction Act capped insulin costs, and Medicare is expanding GLP-1 coverage for weight management starting in some 2026 plans.

Aetna has been adding Zepbound (tirzepatide) to more plan formularies since its FDA approval for weight management. Coverage varies by employer plan. Contact Aetna member services to check if your specific plan includes Zepbound and what prior authorization requirements apply.

Many Aetna plans require step therapy, meaning you may need to try lower-cost medications first (such as metformin for diabetes). For weight management, some plans require documented attempts at diet and exercise programs. Your doctor can request a step therapy exception if there is a clinical reason to skip first-line treatments.

With Aetna coverage, Wegovy copays typically range from $25 to $150 per month after your deductible is met, depending on your plan's tier placement. Without coverage, Wegovy costs around $1,300 per month. Novo Nordisk offers a savings card that may reduce your copay further on eligible commercial plans.

Get Started

Find a GLP-1 Clinic That Takes Your Insurance

Search our directory of 2,770 clinics and filter by insurance, medication, and telehealth availability.

Disclaimer: Insurance coverage information is based on publicly available formulary data and may not reflect your specific plan. Coverage, cost, and requirements can change. Always verify with your insurer directly before making treatment decisions.